Day: March 10, 2026

Veteran Technology Executive Brings Public Company, Capital Markets, and Operating Experience to Support Virtuix’s Growth Strategy AUSTIN, Texas, March 10, 2026 (GLOBE NEWSWIRE) — Virtuix Inc. (NASDAQ: VTIX), a leading developer of full-body virtual reality systems, today announced the appointment of Brett Moyer to the Company’s Board of Directors, effective immediately. Brett Moyer has served as Chief Financial Officer of Datavault AI (NASDAQ), an AI-driven data experience, valuation, and monetization entity since January 2025, and has been a Director and Chairman of the Board since 2010. He was a founding member of WiSA Technologies and served as president, CEO, and director from 2010 until December 2024, when the company acquired Data Vault Holdings’ assets and expanded its operations as Datavault AI. He has also served as a...

DUBLIN, March 10, 2026 (GLOBE NEWSWIRE) — Trinity Biotech plc (Nasdaq: TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable biosensors, today announced an update on its trading activities for Quarter 4, 2025 and some key business updates. Trading UpdateThe Company expects Quarter 4, 2025 revenue within the range of approximately $11.5 million to $12.5 million. This compares to Quarter 4, 2024 revenue of $15.9 million, which was driven by a substantial increase in TrinScreen™ HIV sales from $0.4 million in Quarter 4, 2023 to $3.2 million in Quarter 4, 2024. The reduction in revenue between Quarter 4, 2024 and Quarter 4, 2025 was primarily driven by:The residual impact of the disruption to the global health market for HIV testing in 2025 due...

LAS VEGAS, March 10, 2026 (GLOBE NEWSWIRE) — VenHub Global, Inc. (NASDAQ: VHUB) (“VenHub” or the “Company”), a leader in fully autonomous Smart Store technology, today announced it has expanded its integration with Stripe, a programmable financial services company, to power a unified payments layer across VenHub’s growing global network of fully robotic Smart Stores. Building on an existing relationship, the expanded collaboration formalizes Stripe as VenHub’s primary payments infrastructure partner for its platform, enabling faster global expansion with seamless, secure, and flexible payment experiences. Stripe will serve as VenHub’s primary payments infrastructure, while allowing flexibility to support retailer- or regional-specific payment requirements. Under this enhanced collaboration, VenHub is rolling out a fully integrated...

With commercialization of its advanced optical engines under way, the Company intends to reveal its latest product advancements to industry leadersBlazar4Channel BlazarSAN JOSE, Calif., March 10, 2026 (GLOBE NEWSWIRE) — POET Technologies Inc. (“POET” or the “Company“) (NASDAQ: POET), a leader in the design and implementation of highly-integrated optical engines and light sources for artificial intelligence networks, today announced it plans to perform live demonstrations of its two leading external light source (ELS) products at the annual Optical Fiber Communications (OFC) Conference, which will be held at the Los Angeles Convention Center from March 16-19, 2026. POET’s executive management team and engineers will be meeting customers and industry analysts at the Company’s Booth No. 339 during...

Results demonstrated early signals of C-peptide preservation T1D key opinion leader, Michael J. Haller, MD, provided a recorded webinar reviewing the SAB-142 Phase 1 data MIAMI, March 10, 2026 (GLOBE NEWSWIRE) — SAB Biotherapeutics, Inc. (Nasdaq: SABS), a clinical-stage biopharmaceutical company developing a fully human anti-thymocyte immunoglobulin (hATG) for type 1 diabetes (T1D) and other autoimmune diseases, today announced additional data from the Phase 1 HUman anti-thymocyte biologic in first-in-MAN (HUMAN) clinical trial of SAB-142. The established T1D adult patient cohort demonstrated early signals of C-peptide preservation which aligned with the anticipated mechanism of action of SAB-142. In the T1D cohort (n=6), SAB-142 treated study participants (n=4) showed no decrease in C-peptide levels at Day 120 compared to baseline....

EDAP to Present at Oppenheimer 36th Annual Healthcare MedTech & Services Conference Company to Present and Host 1×1 Investor Meetings on Wednesday, March 18th, 2026 AUSTIN, Texas, March 10, 2026 — EDAP TMS SA (Nasdaq: EDAP) (“the Company”), the global leader in robotic energy-based therapies, today announced that Ryan Rhodes, Chief Executive Officer, is scheduled to present and, together with Ken Mobeck, Chief Financial Officer, will host 1×1 investor meetings at the upcoming Oppenheimer 36th Annual Healthcare MedTech & Services Conference. Date: Wednesday, March 18th Time: 12:00-12:30 PM ET Format: Virtual Presentation and 1×1 investor meetings Webcast:https://event.summitcast.com/view/2MZVg3DCx8a3zxe3mMMekq/6YGp8gAgsNuJhACXjn75JB The live and archived webcast of the presentation can be accessed in the...

Kane also signs U.S.-based contract sales agents WINNIPEG, Manitoba, March 10, 2026 (GLOBE NEWSWIRE) — Kane Biotech Inc. (Kane or the Company), transforming wound care with three FDA 510(k) cleared and two Health Canada approved formats, is pleased to announce two significant expansions to its U.S. commercialization strategy as it prepares for nationwide growth of its advanced wound care portfolio, including the revyve® Antimicrobial Wound Gel. These strategic steps include the signing of a federally aligned distribution partnership to support entry into the U.S. Veterans Affairs (VA) market, the U.S. Department of Defense (DOD), and U.S. Indian Health Services (IHS) and the signing of multiple independent sales representative agreements. U.S. FDA 510(k) cleared and Health Canada approved revyve Antimicrobial Wound Gel and revyve...

Vancouver, BC, Canada, March 10, 2026 (GLOBE NEWSWIRE) — WestKam Gold Corp. (TSXV:WKG) (the “Company”) is pleased to announce that it will be changing its name to “Big Bear Gold Corp.” effective Thursday, March 12, 2026. The Company’s common shares will commence trading on the TSX Venture Exchange under the new name “Big Bear Gold Corp.” at the opening of trading on March 12, 2026, under the new trading symbol “BEAR”.  The Company’s new CUSIP number is 088936109 and its new ISIN number is CA0889361097. There is no change in the share capital of the Company and no action will be required by existing shareholders with respect to the name change.  Certificates representing common shares of WestKam Gold Corp. will not be affected by the name change and will not need to be exchanged.  The Company encourages any shareholders with any...